SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review

1. Escobar, C.
2. Barrios, V.
3. Cosín, J.
4. Gámez Martínez, J.M.
5. Huelmos Rodrigo, A.I.
6. Ortíz Cortés, C.
7. Torres Llergo, J.
8. Requeijo, C.
9. Solà, I.
10. Martínez Zapata, M.J.